DSIJ Mindshare

Bearish behaviour dominated the domestic markets on Tuesday as Sensex tanked by 660.63 points or 1.80 per cent to settle at 36,033.06 while Nifty fell by 195.35 points or 1.81 per cent to close at 10,607.35.

Vaishali Pharma Limited has launched Vipravita C (Vitamin C supplements) for domestic as well as international market to boost immunity against various prevailing diseases. These supplements are available in different variants like Vitamin C chewable tablets, Vitamin C effervescent tablets and Vitamin C with zinc combo.

On Tuesday, pharma major Cipla Limited declared that it has been granted approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL by United States Food and Drug Administration (USFDA).

At the end of FY20, the bank reported its Tier I capital adequacy ratio at 15.80 per cent, well above the regulatory requirement. These fundraising plans add additional strength to its core fundamentals. The CASA ratio at 25 per cent (Rs 1,000 crore) along with debt funds can be expected to maintain a low cost of borrowing.

The rating agency Fitch in its latest report said that a near-term recovery for India's non-banking financial institutions is not probable, as the sector continues to wrestle with the fallout of Coronavirus pandemic